Eluxadoline Demonstrates Efficacy in IBS-D Loperamide Treatment Failures

被引：0
|
作者：
Lacy, Brian [1 ]
Almenoff, June [2 ]
Andrae, David [2 ]
Turner, Lisa [2 ]
Lopez, Rocio [2 ]
Dove, Scott [2 ]
Covington, Paul [2 ]
机构：
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[2] Furiex Pharmaceut, Morrisville, NC USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2014年 / 109卷
关键词：
D O I：
10.14309/00000434-201410002-01792
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1792
引用
收藏
页码：S530 / S530
页数：1
相关论文
共 50 条
  • [1] Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use
    Lacy, Brian E.
    Chey, William D.
    Cash, Brooks D.
    Lembo, Anthony J.
    Dove, Leonard S.
    Covington, Paul S.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (06): : 924 - 932
  • [2] Efficacy and Safety of Eluxadoline in IBS-D Patients Who Report Prior Inadequate Symptom Control with Loperamide
    Lacy, Brian E.
    Chey, William D.
    Cash, Brooks D.
    Lembo, Anthony J.
    Dove, Leonard S.
    Covington, Paul S.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S249 - S250
  • [3] Eluxadoline Demonstrates Efficacy for the Treatment of Irritable Bowel Syndrome (IBS) With Diarrhea (IBS-D) Among Multiple Clinically Relevant Patient Subgroups
    Lacy, Brian E.
    Chey, William
    Lembo, Anthony J.
    Dove, Leonard S.
    Covington, Paul S.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S747 - S747
  • [4] ELUXADOLINE DEMONSTRATES EFFICACY FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME (IBS) WITH DIARRHOEA (IBS-D) AMONG MULTIPLE CLINICALLY RELEVANT PATIENT SUBGROUPS
    Lacy, B.
    Chey, W.
    Lembo, A.
    Dove, L. S.
    Covington, P. S.
    [J]. GUT, 2016, 65 : A42 - A43
  • [5] Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use (vol 112, pg 924, 2017)
    Lacy, Brian E.
    Chey, William D.
    Cash, Brooks D.
    Lembo, Anthony J.
    Dove, Leonard S.
    Covington, Paul S.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (07): : 1210 - 1210
  • [6] Safety of Eluxadoline in Patients With IBS-D Without a Gallbladder
    Cash, Brooks D.
    Lacy, Brian E.
    Schoenfeld, Philip S.
    Dove, Leonard S.
    Covington, Paul S.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (10): : 1619 - 1620
  • [7] Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials
    Lacy, Brian E.
    Harris, Lucinda A.
    Chang, Lin
    Lucak, Susan
    Gutman, Catherine
    Dove, Leonard S.
    Covington, Paul S.
    Lembo, Anthony
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
  • [8] Novel Therapies in IBS-D Treatment
    Judy Nee
    Mohammed Zakari
    Anthony J. Lembo
    [J]. Current Treatment Options in Gastroenterology, 2015, 13 (4) : 432 - 440
  • [9] Effects of treatment with eluxadoline on abdominal pain in patients with IBS-D: Additional post hoc analyses of Phase 3 trials
    Lembo, Anthony J.
    Covington, Paul S.
    Dove, Leonard S.
    Andrae, David A.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2020, 32 (04):
  • [10] TREATMENT OF IBS-D CASES THROUGH RIFAXIMIN
    Shabir, Saba
    Gul, Qamar
    Zia, Jawariya
    [J]. INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (03): : 6517 - 6521
12345